Structure and protein design of a human platelet function inhibitor.
Dai, J., Liu, J., Deng, Y., Smith, T.M., Lu, M.(2004) Cell 116: 649-659
- PubMed: 15006348 
- DOI: https://doi.org/10.1016/s0092-8674(04)00172-2
- Primary Citation of Related Structures:  
1S18, 1S1D - PubMed Abstract: 
Hematophagous arthropods secrete a salivary apyrase that inhibits platelet activation by catabolizing ADP released from damaged tissues and blood cells. We report the X-ray crystal structures of a human enzyme of the soluble apyrase family in its apo state and bound to a substrate analog. The structures reveal a nucleotide binding domain comprising a five-blade beta propeller, binding determinants of the substrate and the active site, and an unusual calcium binding site with a potential regulatory function. Using a comparative structural biology approach, we were able to redesign the human apyrase so as to enhance its ADPase activity by more than 100-fold. The engineered enzyme is a potent inhibitor of platelet aggregation and may serve as the basis for the development of a new class of antithrombotic agents.
Organizational Affiliation: 
Department of Biochemistry, Weill Medical College of Cornell University, New York, NY 10021, USA.